Promising drug for Post-Transplant blood issues falls short in early trial

This study tested a drug called fostamatinib to help people whose blood cell counts drop after a stem cell transplant. The goal was to see if the drug could raise red blood cells or platelets without needing transfusions. The trial was stopped early after enrolling only one person, so we don't have enough information to know if it works.